| Literature DB >> 28846095 |
Maria Skamagki1, Cristina Correia2, Percy Yeung3, Timour Baslan4, Samuel Beck5, Cheng Zhang2, Christian A Ross2, Lam Dang1, Zhong Liu6, Simona Giunta7, Tzu-Pei Chang1, Joye Wang1, Aparna Ananthanarayanan1, Martina Bohndorf8, Benedikt Bosbach4, James Adjaye8, Hironori Funabiki7, Jonghwan Kim5, Scott Lowe4, James J Collins9, Chi-Wei Lu3, Hu Li2, Rui Zhao6, Kitai Kim1.
Abstract
Induced pluripotent stem cells (iPSCs), which are used to produce transplantable tissues, may particularly benefit older patients, who are more likely to suffer from degenerative diseases. However, iPSCs generated from aged donors (A-iPSCs) exhibit higher genomic instability, defects in apoptosis and a blunted DNA damage response compared with iPSCs generated from younger donors. We demonstrated that A-iPSCs exhibit excessive glutathione-mediated reactive oxygen species (ROS) scavenging activity, which blocks the DNA damage response and apoptosis and permits survival of cells with genomic instability. We found that the pluripotency factor ZSCAN10 is poorly expressed in A-iPSCs and addition of ZSCAN10 to the four Yamanaka factors (OCT4, SOX2, KLF4 and c-MYC) during A-iPSC reprogramming normalizes ROS-glutathione homeostasis and the DNA damage response, and recovers genomic stability. Correcting the genomic instability of A-iPSCs will ultimately enhance our ability to produce histocompatible functional tissues from older patients' own cells that are safe for transplantation.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28846095 PMCID: PMC5843481 DOI: 10.1038/ncb3598
Source DB: PubMed Journal: Nat Cell Biol ISSN: 1465-7392 Impact factor: 28.824